Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Muscle Biopsy

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Muscle Biopsy1
  • Lateral Transperitoneal La1
  • Posterior Ra1

Active Sponsors

  • Imperial College London1
  • Jagiellonian University1
  • Barts & The London NHS Trust1
  • Queen Mary University of London1

Top Investigators

Related Conditions

  • Pheochromocytoma2
  • Adrenal Tumor1
  • Metabolic Myopathy1
  • Cushing Syndrome1
  • Cushings Syndrome1

Activity Timeline